Lv7
4940 积分 2022-09-14 加入
Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors
15天前
已完结
Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors
15天前
已完结
A Second Factor VIIIa Mimetic for Hemophilia A
15天前
已关闭
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial
28天前
已完结
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
1个月前
已完结
Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo‐controlled, 52‐week trial
1个月前
已完结
Considering Over-Dispersion in the Sample Size Calculation for Clinical Trials With Repeated Count Measurements
3个月前
已完结
Sample size calculation for clinical trials with correlated count measurements based on the negative binomial distribution
3个月前
已完结
Pirtobrutinib in Chinese patients with relapsed or refractory B‐cell malignancies: A single‐arm, open‐label, phase 2, multicenter trial
3个月前
已完结
Pirtobrutinib, a Non-Covalent (reversible) BTK Inhibitor, in Mantle Cell Lymphoma Patients Previously Treated with a Covalent BTK Inhibitor: Results from a China Phase 2 Study
3个月前
已完结
皖公网安备34019202002308
